Pure Global

Nail treatment solution

Access comprehensive regulatory information for Nail treatment solution in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Arrotex Pharmaceuticals Pty Ltd, manufactured by Advantice Health LLC in United States of America. The device registration started on January 03, 2023.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class IIa
Class IIa
Nail treatment solution
Australia TGA ARTG Registered Device
Good Name: Arrotex Pharmaceuticals Pty Ltd - Nail treatment solution
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

A non-sterile topical solution in a plastic applicator with a silicone drop tip for application to nails. It promotes healing of discoloured & deformed nails (onychodystrophy) due to onychomycosis or psoriasis. It hydrates & smooths the outer layers of the nail plate & changes the nail's microenvironment (low pH, altered osmotic environment) to create an antagonistic environment for microorganisms & improves nail surface integrity, creating a barrier which prevents growth of fungi & bacteria.

Device Classification
Risk Class
Class IIa
Product Type
Single Device Product
ARTG Category
General
Registration Information
Start Date
January 03, 2023
Effective Date
January 03, 2023
Manufacturer
Country
United States of America
Address
7 East Frederick Place, Cedar Knolls, New Jersey, 07927